Abstract
The aim of this study was to estimate the mapping model for EuroQol-5D (EQ-5D) utility values using the health assessment questionnaire disability index (HAQ-DI), pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) in a large, nationwide cohort of rheumatoid arthritis (RA) patients in Korea. The KORean Observational study Network for Arthritis (KORONA) registry data on 3557 patients with RA were used. Data were randomly divided into a modeling set (80 % of the data) and a validation set (20 % of the data). The ordinary least squares (OLS), Tobit, and two-part model methods were employed to construct a model to map to the EQ-5D index. Using a combination of HAQ-DI, pain VAS, and DAS28, four model versions were examined. To evaluate the predictive accuracy of the models, the root-mean-square error (RMSE) and mean absolute error (MAE) were calculated using the validation dataset. A model that included HAQ-DI, pain VAS, and DAS28 produced the highest adjusted R 2 as well as the lowest Akaike information criterion, RMSE, and MAE, regardless of the statistical methods used in modeling set. The mapping equation of the OLS method is given as EQ-5D = 0.95−0.21 × HAQ-DI−0.24 × pain VAS/100–0.01 × DAS28 (adjusted R 2 = 57.6 %, RMSE = 0.1654 and MAE = 0.1222). Also in the validation set, the RMSE and MAE were shown to be the smallest. The model with HAQ-DI, pain VAS, and DAS28 showed the best performance, and this mapping model enabled the estimation of an EQ-5D value for RA patients in whom utility values have not been measured.
Similar content being viewed by others
References
Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M (2010) Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis. Pharmacoeconomics 28(6):477–487. doi:10.2165/11533010-000000000-00000
Kontodimopoulos N, Bozios P, Yfantopoulos J, Niakas D (2013) Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients. Eur J Health Econ 14(2):307–314. doi:10.1007/s10198-012-0376-9
The EuroQol Group (1990) EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208
Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21(2):271–292
Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M (2002) Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 40(2):113–128
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324
Prevoo ML, Van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48
Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137–145
Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A (2006) A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol Assess 10 (42):iii–iv, xi–xiii, 1–229
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O’Dell J, Paulus H, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D (2008) Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 67(10):1360–1364. doi:10.1136/ard.2008.091454
Pease C, Pope JE, Truong D, Bombardier C, Widdifield J, Thorne JC, Paul Haraoui B, Psaradellis E, Sampalis J, Bonner A (2011) Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin Arthritis Rheum 41(1):81–89. doi:10.1016/j.semarthrit.2010.09.004
Won S, Sung YK, Cho SK, Choi CB, Koh E, Kim SK, Kim J, Kim TH, Kim HA, Nah SS, Bang SY, Suh CH, Shim SC, Yoo DH, Yoon BY, Lee SH, Lee SW, Lee SS, Lee YA, Lee JJ, Lee JS, Lee HS, Lim MK, Jun JB, Jeon CH, Jung YO, Chung WT, Cha HS, Choe JY, Hong SJ, Bae SC (2014) Prediction for TNF inhibitor users in RA patients according to reimbursement criteria based on DAS28 (In Korean). J Rheum Dis 21(2):64–73
Hernandez Alava M, Wailoo A, Wolfe F, Michaud K (2013) The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology (Oxford) 52(5):944–950. doi:10.1093/rheumatology/kes400
Payakachat N, Summers KH, Pleil AM, Murawski MM, Thomas J 3rd, Jennings K, Anderson JG (2009) Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Qual Life Res 18(7):801–813. doi:10.1007/s11136-009-9499-6
Longworth L, Rowen D (2013) Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health 16(1):202–210. doi:10.1016/j.jval.2012.10.010
Brazier JE, Yang Y, Tsuchiya A, Rowen DL (2010) A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 11(2):215–225. doi:10.1007/s10198-009-0168-z
Bansback NJ, Brennan A, Ghatnekar O (2005) Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden. Ann Rheum Dis 64(7):995–1002. doi:10.1136/ard.2004.027565
Brennan A, Bansback N, Reynolds A, Conway P (2004) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. Rheumatol (Oxford) 43(1):62–72. doi:10.1093/rheumatology/keg451
Diamantopoulos A, Benucci M, Capri S, Berger W, Wintfeld N, Giuliani G, Ricciardi W (2012) Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in Italy. J Med Econ 15(3):576–585. doi:10.3111/13696998.2012.665110
Tanno M, Nakamura I, Ito K, Tanaka H, Ohta H, Kobayashi M, Tachihara A, Nagashima M, Yoshino S, Nakajima A (2006) Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis. Mod Rheumatol 16(2):77–84. doi:10.1007/s10165-006-0461-y
Carreño A, Fernández I, Badia X, Varela C, Roset M (2011) Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. Value Health 14(1):192–200. doi:10.1016/j.jval.2010.11.001
Hernandez Alava M, Wailoo AJ, Ara R (2012) Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health 15(3):550–561. doi:10.1016/j.jval.2011.12.014
Wolfe F, Michaud K, Wallenstein G (2010) Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis. J Rheumatol 37(8):1615–1625. doi:10.3899/jrheum.100043
Chiu YM, Lai MS, Lin HY, Lang HC, Lee LJ, Wang JD (2014) Disease activity affects all domains of quality of life in patients with rheumatoid arthritis and is modified by disease duration. Clin Exp Rheumatol 32(6):898–903
Cho SK, Kim D, Jun JB, Bae SC, Sung YK (2013) Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA). Rheumatol Int 33(1):93–102. doi:10.1007/s00296-011-2352-6
Lubetkin EI, Jia H, Franks P, Gold MR (2005) Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population. Qual Life Res 14(10):2187–2196. doi:10.1007/s11136-005-8028-5
Sung YK, Cho SK, Choi CB, Park SY, Shim J, Ahn JK, Bang SY, Cha HS, Choe JY, Chung WT, Her M, Hong SJ, Hong YK, Joung CI, Jun JB, Jung YO, Kang YM, Kim DY, Kim HR, Kim HA, Kim J, Kim SK, Kim SI, Kim TH, Kim TJ, Koh E, Lee CK, Lee HS, Lee J, Lee SH, Lee SH, Lee SS, Lee SW, Lee YA, Nah SS, Park SH, Sheen DH, Shim SC, Gyu Song G, Suh CH, Uhm WS, Yoo DH, Yoo WH, Yoon BY, Bae SC (2012) Korean observational study network for arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin Arthritis Rheum 41(6):745–751. doi:10.1016/j.semarthrit.2011.09.007
Sung YK, Cho SK, Choi CB, Bae SC (2013) Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol Int 33(6):1525–1532. doi:10.1007/s00296-012-2590-2
Kim MH, Cho YS, Uhm WS, Kim S, Bae SC (2005) Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 14(5):1401–1406
Bae SC, Cook EF, Kim SY (1998) Psychometric evaluation of a Korean health assessment questionnaire for clinical research. J Rheumatol 25(10):1975–1979
Hawker GA, Mian S, Kendzerska T, French M (2011) Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res 63(S11):S240–S252. doi:10.1002/acr.20543
Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O’Dell JR, Kazi S (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken) 64(5):640–647. doi:10.1002/acr.21649
Fransen J, Stucki G, van Riel PLCM (2003) Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care Res 49(S5):S214–S224. doi:10.1002/art.11407
Castrejon I, Ortiz AM, Garcia-Vicuna R, Lopez-Bote JP, Humbria A, Carmona L, Gonzalez-Alvaro I (2008) Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 26(5):769–775
Mela CF, Kopalle PK, Mela CF, Kopalle PK, Mela C, Kopalle P, Mela CF, Kopalle PK (2002) The impact of collinearity on regression analysis: the asymmetric effect of negative and positive correlations. Appl Econ 34(6):667
Yang Y, Wong MY, Lam CL, Wong CK (2014) Improving the mapping of condition-specific health-related quality of life onto SF-6D score. Qual Life Res. doi:10.1007/s11136-014-0668-x
Longworth L, Yang Y, Young T, Mulhern B, Hernandez Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, Devianee Keetharuth A, Brazier J (2014) Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess 18(9):1–224. doi:10.3310/hta18090
Dakin H, Gray A, Murray D (2013) Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score. Qual Life Res 22(3):683–694. doi:10.1007/s11136-012-0189-4
Huang IC, Frangakis C, Atkinson MJ, Willke RJ, Leite WL, Vogel WB, Wu AW (2008) Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease. Health Serv Res 43(1 Pt 1):327–339. doi:10.1111/j.1475-6773.2007.00745.x
Longworth L, Rowen D (2011) NICE DSU Technical Support Document 10: The use of mapping methods to estimate health state utility values
Burnham KP, Anderson (2002) Model selection and multimodel inference, 2nd edn. Springer, New York. doi:10.1007/b97636
Wagenmakers EJ, Farrell S (2004) AIC model selection using Akaike weights. Psychon Bull Rev 11(1):192–196
Kim SH, Jo M-W, Kim H-J, Ahn J-H (2012) Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients. Health Qual Life Outcomes 10(1):151
Hernandez Alava M, Wailoo A, Wolfe F, Michaud K (2014) A comparison of direct and indirect methods for the estimation of health utilities from clinical outcomes. Med Decis Making 34(7):919–930. doi:10.1177/0272989x13500720
Ota H, Tanno M, Tanaka H, Kobayashi M, Yoshino S (2003) Correlation between the health assessment questionnaire (haq) and utility value in rheumatoid arthritis patients. In: Paper presented at the ISPOR first Asia-Pacific conference, Kobe, Japan
Goldsmith KA, Dyer MT, Buxton MJ, Sharples LD (2010) Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Health Qual Life Outcomes 8:54. doi:10.1186/1477-7525-8-54
Park HA (2013) The Korea national health and nutrition examination survey as a primary data source. Korean J Fam Med 34(2):79. doi:10.4082/kjfm.2013.34.2.79
In-depth Analyses of the Third National Health and Nutrition Examination Survey: the Health Interview and Health Attitude Survey Part (In Korean) (2007). Korea Institute for Health and Social Affairs (KIHASA) and Korea Centers for Disease Control & Prevention
Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J (2009) International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 12(8):1194–1200. doi:10.1111/j.1524-4733.2009.00581.x
Pennington B, Davis S (2014) Mapping from the Health Assessment Questionnaire to the EQ-5D: the impact of different algorithms on cost-effectiveness results. Value Health 17(8):762–771. doi:10.1016/j.jval.2014.11.002
Acknowledgments
This study was supported by a Grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant Number: HI10C2020).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interests
Hye-Lin Kim, Dam Kim, Eun Jin Jang, Min-Young Lee, Hyun Jin Song, Sun-Young Park, Soo-Kyung Cho, Yoon-Kyoung Sung, Chan-Bum Choi, Soyoung Won, So-Young Bang, Hoon-Suk Cha, Jung-Yoon Choe, Won Tae Chung, Seung-Jae Hong, Jae-Bum Jun, Jinseok Kim, Seong-Kyu Kim, Tae-Hwan Kim, Tae-Jong Kim, Eunmi Koh, Hwajeong Lee, Hye-Soon Lee, Jisoo Lee, Shin-Seok Lee, Sung Won Lee, Sung-Hoon Park, Seung-Cheol Shim, Dae-Hyun Yoo, Bo Young Yoon, Sang-Cheol Bae, and Eui-Kyung Lee declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Hye-Lin Kim and Dam Kim contributed equally to this article as co-first authors.
Sang-Cheol Bae and Eui-Kyung Lee contributed equally to this article as co-corresponding authors.
Rights and permissions
About this article
Cite this article
Kim, HL., Kim, D., Jang, E.J. et al. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data. Rheumatol Int 36, 505–513 (2016). https://doi.org/10.1007/s00296-016-3427-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-016-3427-1